Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | LTA4H | P09960 | 4/20 | 0.32 |
| ▸ | ACHE | P22303 | 6/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | NAAA | Q02083 | 1/20 | 0.31 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.30 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29389722 | 0.86 | CA1 (0.44) | CA1CA2TDP1LTA4HACHE | |
| SCHEMBL29389239 | 0.86 | POLB (0.32) | POLBTDP1ACHE | |
| SCHEMBL10698634 | 0.77 | NAAA (0.47) | CA1CA2LTA4HNAAA | |
| SCHEMBL11198736 | 0.76 | NAAA (0.55) | CA1CA2TDP1NAAAMEN1 | |
| SCHEMBL28650100 | 0.76 | TDP1 (0.31) | CA1CA2TDP1MEN1KMT2A | |
| SCHEMBL892182 | 0.75 | CA1 (0.46) | CA1CA2LTA4HACHE | |
| SCHEMBL5497225 | 0.74 | NAAA (0.58) | TDP1NAAAMEN1KMT2A | |
| SCHEMBL11184933 | 0.74 | NAAA (0.58) | TDP1NAAAMEN1KMT2A | |
| SCHEMBL11280682 | 0.73 | CA1 (0.45) | CA1CA2LTA4HNAAA | |
| SCHEMBL11699076 | 0.73 | CA1 (0.45) | CA1CA2LTA4HACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113710331-A | Antimicrobial mixture | 西姆莱斯股份公司 | 2021-11-26 | — | — | CN | disclosed |